日本語English简体中文 繁體中文

520A J-Pharma Co.,Ltd.ジェイファーマTSE Growth / Pharmaceuticals

0 posts

J-Pharma Co.,Ltd. (520A) at a glance

Code
520A
Company
J-Pharma Co.,Ltd.
Local name
ジェイファーマ
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥317 -8.0 (-2.46%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

J-Pharma Co.,Ltd. (520A) Stock Price History

J-Pharma Co.,Ltd. closed at ¥317 on Nov 20, 2026, −18.1% over 1 month.

2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥462¥317Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥462Oct 28
1-Month Low¥317Nov 20
1-Week Change−11.2%vs Nov 13
1-Month Change−18.1%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥81,912 today (−18.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −18.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥317−8−2.46%
Nov 19 (Thu)¥325−11−3.27%
Nov 18 (Wed)¥336+1+0.30%
Nov 17 (Tue)¥335−18−5.10%
Nov 16 (Mon)¥353−4−1.12%
Nov 13 (Fri)¥357−7−1.92%
Nov 12 (Thu)¥364+4+1.11%
Nov 11 (Wed)¥360+7+1.98%
Nov 10 (Tue)¥353+14+4.13%
Nov 9 (Mon)¥339+7+2.11%
2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥515¥270Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥515Sep 10
3-Month Low¥270Aug 24
1-Month Change−18.1%vs Oct 20
3-Month Change+12.8%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥112,811 today (+12.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved +12.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥317−8−2.46%
Nov 19 (Thu)¥325−11−3.27%
Nov 18 (Wed)¥336+1+0.30%
Nov 17 (Tue)¥335−18−5.10%
Nov 16 (Mon)¥353−4−1.12%
Nov 13 (Fri)¥357−7−1.92%
Nov 12 (Thu)¥364+4+1.11%
Nov 11 (Wed)¥360+7+1.98%
Nov 10 (Tue)¥353+14+4.13%
Nov 9 (Mon)¥339+7+2.11%
2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥526¥261May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥526May 29
6-Month Low¥261Jul 30
3-Month Change+12.8%vs Aug 20
6-Month Change−34.5%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥65,496 today (−34.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −34.5%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥317−21.3%
Oct 2026¥403+0.2%
Sep 2026¥402+27.2%
Aug 2026¥316+17.5%
Jul 2026¥269−11.8%
Jun 2026¥305−42.0%
May 2026¥526−5.1%
2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥738¥261Mar 25Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥738Mar 27
52-Week Low¥261Jul 30
Year to Date―
From 52-Week High−57.0%Mar 27

If you had invested ¥100,000 1 year ago, it would be worth ¥45,286 today (−54.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +5.0%, while this stock moved −54.7%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥317−21.3%
Oct 2026¥403+0.2%
Sep 2026¥402+27.2%
Aug 2026¥316+17.5%
Jul 2026¥269−11.8%
Jun 2026¥305−42.0%
May 2026¥526−5.1%
Apr 2026¥554−24.0%
Mar 2026¥729―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Mar 2026). Please check the latest prices before trading.

J-Pharma Co.,Ltd. (520A) financial indicators

PBR
2.06
ROE
-102.85%
Dividend yield
0.00%

See all financial indicators for J-Pharma Co.,Ltd. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of J-Pharma Co.,Ltd. (520A)

Business overview

The company is a venture pursuing drug discovery targeting SLC transporters. Aiming at the global market, it carries out clinical development with the goal of obtaining approval from major regulators such as the US FDA. It works with CROs and research institutions in the US and Europe and is developing treatments in areas including biliary tract cancer and multiple sclerosis.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR2.06xAbove the sector median of 1.86x (No. 43 from the lowest)
ROE-102.85%No. 51 in the sector (highest first); median 4.17%
Market cap¥5.7 bnNo. 59 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

High since 3/25¥7383/27
Low since 3/25¥2617/30
Current position11.7%Where the low is 0% and the high is 100% (close on 11/20: ¥317)

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers3 timesLatest: 10/26 (No. 39)
Top 50 losers2 timesLatest: 10/29 (No. 27)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (5).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the J-Pharma Co.,Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English